FREE Shippingto US, AU, UK and EU on all orders over $149


  • New Arrivals
  • Sale
  • Hot items

Immard (Hydroxychloroquine) 200 mg, 30 tablets


Brands:: ipca (India)


Common brands: Plaquenil®, JAMP Hydroxychloroquine Sulf, APO-Hydroxyquine, MINT-Hydroxychloroquine, MYLAN-Hydroxychloroquine, Advaquenil, Axokine, Chloguin, Dimard, Dolquine, Duloc, Duroc, Ercoquin, Evoquin, Futarhomal, Geniquin, Haloxin, HCQS, Hequinel, Hydroquin, Hydroquine, Hyquin, Ilinol, Metirel, Oxcq, Oxiklorin, Planil, Plaquinol, Quinoric, Reconil, Reuquinol, Roquin, Supretic, Winflam, Yuma, Zyq


1 tablet contains Hydroxychloroquine Sulfate 200 mg


Indications for use

Rheumatoid arthritis; lupus erythematosus (systemic and discoid). Juvenile arthritis. Hypercalcemia associated with sarcoidosis.

Malaria: treatment of acute attacks and suppressive therapy of malaria caused by Plasmodium vivax, Plasmodium ovale and Plasmodium malariae (excluding extra-erythrocytic forms and hydroxychloroquine-resistant cases) and susceptible strains of Plasmodium falciparum (excluding hydroxychloroquine-resistant strains); radical treatment of malaria caused by susceptible strains of Plasmodium falciparum.

Use: Off-Label: Adult

Dermatomyositis, cutaneous disease; Porphyria cutanea tarda; Primary Sjögren syndrome (extraglandular manifestations); Q fever (Coxiella burnetii); Sarcoidosis, arthropathy; Sarcoidosis, cutaneous disease (extensive)


Method of administration

Inside, during meals or with a glass of milk. 200 mg of hydroxychloroquine sulfate is equivalent to 155 mg of hydroxychloroquine base.

Rheumatoid arthritis: the initial dose in adults is 400-600 mg / day, the maintenance dose is 200-400 mg / day. Juvenile arthritis: the dose should not exceed 6.5 mg / kg or 400 mg / day (the lowest dose is chosen).

Discoid and systemic lupus erythematosus: the initial dose for adults is 400-800 mg / day, the maintenance dose is 200-400 mg / day.

Photodermatosis: up to 400 mg / day.

Treatment should be limited to periods of maximum sun exposure.

Malaria: suppressive therapy in adults – 400 mg / day every 7 days;

in children (including infants), the weekly suppressive dose is 6.5 mg / kg, but regardless of body weight, it should not exceed the adult dose (400 mg).

If conditions allow, suppressive therapy is prescribed 2 weeks before exposure, otherwise, an initial double dose can be prescribed: 800 mg for adults and 12.9 mg / kg (but not exceeding 800 mg) for children, divided into 2 doses with an interval of 6 h. Suppressive therapy should be continued for 8 weeks after leaving the endemic area.


Hypersensitivity, pregnancy (may be used for “vital” indications), lactation, childhood (long-term therapy).


Side effects

On the part of the musculoskeletal and nervous systems: myopathy or neuromyopathy, leading to increasing myasthenia gravis and atrophy of the proximal muscle groups; sensory disturbances, decreased tendon reflexes, abnormal nerve conduction, muscle weakness; headache, dizziness, nervousness, psychosis, emotional lability, convulsions, ataxia, irritability.

From the senses: tinnitus, hearing loss, photophobia, impaired visual acuity, impaired accommodation, edema and opacity of the cornea, scotoma; with prolonged use of large doses – retinopathy (including with pigmentation disorders and visual field defects), optic nerve atrophy, keratopathy, ciliary muscle dysfunction.

On the part of the CVS: CMP, AV blockade, decreased myocardial contractility, myocardial hypertrophy; with long-term therapy with large doses – myocardial dystrophy.

From the digestive system: nausea, vomiting (rarely), loss of appetite, abdominal pain of a spastic nature, diarrhea; hepatotoxicity (impaired liver function, liver failure).

Additional information



There are no reviews yet.

Be the first to review “Immard (Hydroxychloroquine) 200 mg, 30 tablets”

Your email address will not be published. Required fields are marked *